Literature DB >> 11231628

Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype.

N Wang1, S K Chintala, M E Fini, J S Schuman.   

Abstract

The glaucomas are a group of optic neuropathies comprising the leading cause of irreversible blindness worldwide. Elevated intraocular pressure due to a reduction in normal aqueous outflow is a major causal risk factor. We found that endothelial leukocyte adhesion molecule-1 (ELAM-1), the earliest marker for the atherosclerotic plaque in the vasculature, was consistently present on trabecular meshwork (TM) cells in the outflow pathways of eyes with glaucomas of diverse etiology. We determined expression of ELAM-1 to be controlled by activation of an interleukin-1 (IL-1) autocrine feedback loop through transcription factor NF-kappaB, and activity of this signaling pathway was shown to protect TM cells against oxidative stress. These findings characterize a protective stress response specific to the eye's aqueous outflow pathways and provide the first known diagnostic indicator of glaucomatous TM cells. They further indicate that common mechanisms contribute to the pathophysiology of the glaucomas and vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231628      PMCID: PMC1945815          DOI: 10.1038/85446

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  38 in total

1.  Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways.

Authors:  H Loppnow; P Libby
Journal:  Exp Cell Res       Date:  1992-02       Impact factor: 3.905

2.  Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts.

Authors:  S Kumar; A J Millis; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.

Authors:  M S Diamond; D E Staunton; S D Marlin; T A Springer
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Expression of HLA class I and II antigens on cells of the human trabecular meshwork.

Authors:  M G Lynch; J S Peeler; R H Brown; J Y Niederkorn
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

5.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer.

Authors:  J A Maier; P Voulalas; D Roeder; T Maciag
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

Review 6.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

7.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

8.  Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes.

Authors:  E Lütjen-Drecoll; T Shimizu; M Rohrbach; J W Rohen
Journal:  Exp Eye Res       Date:  1986-05       Impact factor: 3.467

Review 9.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11

10.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.

Authors:  R Schreck; P Rieber; P A Baeuerle
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  94 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Profiling of Cytokines Secreted by Conventional Aqueous Outflow Pathway Endothelial Cells Activated In Vitro and Ex Vivo With Laser Irradiation.

Authors:  Jorge A Alvarado; Phuonglan Chau; Jianfeng Wu; Richard Juster; Amde Selassie Shifera; Michael Geske
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

3.  Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.

Authors:  Joshua A Wood; Clayton T McKee; Sara M Thomasy; Marion E Fischer; Nihar M Shah; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-02       Impact factor: 4.799

4.  Cellular senescence in the glaucomatous outflow pathway.

Authors:  Paloma B Liton; Pratap Challa; Sandra Stinnett; Coralia Luna; David L Epstein; Pedro Gonzalez
Journal:  Exp Gerontol       Date:  2005 Aug-Sep       Impact factor: 4.032

5.  Aqueous humor outflow: what do we know? Where will it lead us?

Authors:  Michael P Fautsch; Douglas H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

6.  Curcumin attenuates staurosporine-mediated death of retinal ganglion cells.

Authors:  Balabharathi Burugula; Bhagyalaxmi S Ganesh; Shravan K Chintala
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-16       Impact factor: 4.799

Review 7.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

Review 8.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

Review 9.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

10.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.